Patent Assignment
Reel/Frame 065460/0683
Assignment of Assignor's Interest
Recorded: 2023-11-05
Pages: 22
Assignor
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Executed: 2018-09-07
Assignee
PRILENIA THERAPEUTICS DEVELOPMENT LTD.
HAMENOFIM 10, HERZLIYA, 4672561, ISRAEL
Covered Property
(1)
Treatment of Neurodegenerative Eye Disease Using Pridopidine
Application:
17/513,239 →
Publication:
US 2022/0062255
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 4, 2022
From: GEVA, MICHAL; LAUFER, RALPH; ORBACH, ARIC
To: PRILENIA NEUROTHERAPEUTICS LTD.
Reel/Frame 061296/0185 →
Change of Address
Nov 5, 2023
From: PRILENIA NEUROTHERAPEUTICS LTD.
To: PRILENIA NEUROTHERAPEUTICS LTD.
Reel/Frame 065460/0438 →
Assignment of Assignor's Interest
Nov 5, 2023
From: RUSS, HERMANN KURT
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 065460/0673 →